<?xml version="1.0" encoding="UTF-8"?>
<ref id="B181-pharmaceutics-13-00327">
 <label>181.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Hammoud</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Gharib</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Fourmentin</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Elaissari</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Greige-Gerges</surname>
    <given-names>H.</given-names>
   </name>
  </person-group>
  <article-title>Drug-in-hydroxypropyl-beta-cyclodextrin-in-lipoid S100/cholesterol liposomes: Effect of the characteristics of essential oil components on their encapsulation and release</article-title>
  <source>Int. J. Pharm.</source>
  <year>2020</year>
  <volume>579</volume>
  <pub-id pub-id-type="doi">10.1016/j.ijpharm.2020.119151</pub-id>
  <?supplied-pmid 32070761?>
  <pub-id pub-id-type="pmid">32070761</pub-id>
 </element-citation>
</ref>
